Course Listing
Advance your knowledge in engaging, interactive courses developed and taught by leaders in the field.
Browse All MDS Courses
New courses are added regularly. If there are not courses listed in the category you are searching, more will be scheduled at a later date. Check back soon or sign up for email notifications.
Please wait while we gather your results.
2026 International Congress of Parkinson's Disease and Movement Disorders: Recorded Sessions
On Demand
15 Hours
1146 Delve into timely topics from across the field, featuring leading expert lectures from the 2026 International Congress. 900 0.00 https://education.movementdisorders.org/Detail/1146/2026-International-Congress-of-Parkinson's-Disease-and-Movement-Disorders:-Recorded-Sessions https://education.movementdisorders.org/Upload/ActivityImages/IC26_202x10852544.png 2026-10-23T00:00:00 2027-03-23T00:00:00 MDS Education <p><span style="background-color: null;"><strong>TO ACCESS THE MODULE</strong></span></p><p>Access to the 2026 International Congress of Parkinson's Disease and Movement Disorders: Recorded Sessions is free to all MDS members. Log in to your MDS account and click the enroll button to enter the module.</p><p><br></p><p>If you are are non-member who attended the MDS International Congress, a coupon code will be delivered to your email inbox. After logging in to your MDS account, select <em>Module Access </em>above, click the enroll button, and enter the coupon code on the payment page as shown in the image below:</p><p><br></p><p><img src="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/couponcode_11082026104658.png" style="width: 600px;" class="fr-fic fr-dib fr-fil"></p> 0 /Courses/2026-International-Congress-of-Parkinsons-Disease-and-Movement-Disorders-Recorded-Sessions.htm 2026 International Congress of Parkinson's Disease and Movement Disorders: Recorded Sessions 2026-10-23T00:01:08.270 0 0 English On-Demand USA
Recognition and Management of Motor Complications in Parkinson's Disease
On Demand
Interactive
60 Minutes
Foundational / Beginner
CME Credits:1.001149 <p>This module will discuss the presentation of motor complications in Parkinson’s disease, including motor fluctuations and levodopa-induced dyskinesia (LID). Different types of motor fluctuations and LID will be reviewed. In addition, the module will discuss evidence-based therapeutic strategies for the management of motor complications.</p> Deep brain stimulation, Infusion therapy, Medications for motor complications, Medications for motor symptoms, Parkinson Disease/Hypokinetic Movement Disorders, Parkinson's Disease (PD), Therapies-Pharmacological, Therapies-Surgical 60 1.00 https://education.movementdisorders.org/Detail/1149/Recognition-and-Management-of-Motor-Complications-in-Parkinson's-Disease https://education.movementdisorders.org/Upload/ActivityImages/05INTERACT-43-001-Motor-Response-Complications-in-PD-202x108387919.jpg 2026-10-21T00:00:00 2029-10-21T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a class="fr-file" href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Disclosures - Motor Complications in PD_24082026021154.pdf" target="_blank">HERE</a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>METHOD OF PARTICIPATION </strong></p><p>Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed in the Accreditation Statement, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><span style="background-color: null;"><strong>FACULTY</strong></span></p><p>Shen-Yang Lim, MBBS MD FRACP FASc - University of Malaya Medical Centre, Kuala Lumpur, Malaysia</p><p>Camila Aquino, MD, MSc, PhD - University of Calgary, Calgary, Canada</p><p>Regina Katzenschlager, MD - Klinik Donaustadt Vienna, Vienna, Austria</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to: </p><p>1. Identify the clinical characteristics of motor fluctuations in Parkinson’s disease.</p><p>2. Identify the clinical presentation of levodopa-induced dyskinesia and its subtypes, including biphasic dyskinesia and off-related dystonia.</p><p>3. Review the available treatments for the management of motor fluctuations and dyskinesia in Parkinson’s disease.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for students, residents, primary care providers, internists, allied health, non-neurology specialists, and industry who have limited to no movement disorder experience.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Recognition-and-Management-of-Motor-Complications-in-Parkinsons-Disease.htm Recognition and Management of Motor Complications in Parkinson's Disease 2026-10-21T03:01:12.007 0 0 Foundational / Beginner Interactive CME English On-Demand Clinician Fellow Industry Resident Student USA
MDS Case Presentation: Involuntary Movements of the Jaw
On Demand
Case Presentation Series
15 Minutes
Foundational / Beginner
731 This brief 15 minute case presentation will provide the learner with an opportunity to accept the role of a decisive clinician regarding a clinical case of involuntary jaw movement. Care Models, Dopaminergic medications, Medications for motor complications, Medications for motor symptoms, Medications for non-motor symptoms, Parkinson Disease/Hypokinetic Movement Disorders, Parkinson's Disease (PD), Primary Care, Therapies-Pharmacological Alfand Marl F. Dy Closas, MD, FPNA 15 0.00 https://education.movementdisorders.org/Detail/731/MDS-Case-Presentation:-Involuntary-Movements-of-the-Jaw https://education.movementdisorders.org/Upload/ActivityImages/Case-based-Series866197.jpg 2023-08-01T00:00:00 2029-08-01T00:00:00 <p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p> <p>The MDS Case Presentation Series assists learners in developing a step-by-step diagnostic approach to a wide spectrum of movement disorders based on clinical history, phenomenology and investigation findings. </p> <p><span style="text-decoration:underline;">Upon completion of this activity learners will be able to:</span></p><p style="margin-left:30px;">1. Develop a step-by-step diagnostic approach to a wide spectrum of movement disorders based on clinical history, phenomenology and investigation findings. </p> <p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher)</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> <p>Alfand Marl F. Dy Closas, MD, FPNA- St. Louis Hospital, Tacurong City, Philippines</p> MDS Education 0 /Courses/MDS-Case-Presentation-Involuntary-Movements-of-the-Jaw1.htm MDS Case Presentation: Involuntary Movements of the Jaw 2026-10-20T15:00:26.003 0 0 Foundational / Beginner Case Presentation Series English On-Demand Clinician Clinician-Primary Care Fellow Health Professional Industry Resident Student USA
Journal CME 41.08: Distinct brain drivers and shared cerebello-cortical input in ADCY5 and SGCE hyperkinetic movements
On Demand
Journal CME
60 Minutes
Experienced / Intermediate
CME Credits:1.001158 <p>The Journal CME 41.08 article aims to determine how basal ganglia and cerebellar dysfunction drives cortical dysregulation in hyperkinetic movement disorders.</p> Basal Ganglia, Basic/Translational Neuroscience, Chorea/Huntingtons Disease (HD), Dystonia, Etiology & Pathophysiology, Genetics, Hyperkinetic Movement Disorders, Myoclonus, Neuropsychiatric symptoms, Non-motor Symptoms/Disorders, Tics/Tourettes syndrome (TS), Tremor/Essential Tremor (ET) Clément Tarrano, MD, PhD, 60 1.00 https://education.movementdisorders.org/Detail/1158/Journal-CME-41-08:-Distinct-brain-drivers-and-shared-cerebello-cortical-input-in-ADCY5-and-SGCE-hyperkinetic-movements https://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg 2026-10-14T00:00:00 2027-10-14T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Journal%20CME%2041.08-002%20-%20Disclosures_29092026024901.pdf" rel="noopener noreferrer" target="_blank"><u>HERE</u></a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Understand the psychiatric manifestations and brain regions involved in ADCY5- and SGCE-related hyperkinetic movement disorders</p><p>2. Assess the cortical and subcortical nodes involved in motor and non-motor networks in these disorders</p><p>3. Evaluate the role of the cerebellum in the pathophysiology of SGCE-related hyperkinetic movements</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Journal-CME-41.08-Distinct-brain-drivers-and-shared-cerebello-cortical-input-in-ADCY5-and-SGCE-hyperkinetic-movements.htm Journal CME 41.08: Distinct brain drivers and shared cerebello-cortical input in ADCY5 and SGCE hyperkinetic movements Journal CME 41.08 2026-10-14T18:00:59.510 0 0 Experienced / Intermediate Journal CME CME English On-Demand Clinician Fellow Industry Researcher Resident USA
Journal CME 41.09: Transcranial Stimulation enhances dexterity in Parkinson's disease: A randomized sham-controlled trial
On Demand
Journal CME
60 Minutes
Experienced / Intermediate
CME Credits:1.001157 <p>The Journal CME 41.09 article aims to evaluate the effects of repeated transcranial pulse stimulation (TPS) applications on motor symptoms, brain structure, and functional activation in PD.</p> Biomarkers & Diagnostic Tools, Neuroimaging, Non-invasive stimulation, Parkinson Disease/Hypokinetic Movement Disorders, Parkinson's Disease (PD), Rating Scales, Therapies-Other Eva Matt, PhD 60 1.00 https://education.movementdisorders.org/Detail/1157/Journal-CME-41-09:-Transcranial-Stimulation-enhances-dexterity-in-Parkinson's-disease:-A-randomized-sham-controlled-trial https://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg 2026-10-14T00:00:00 2027-10-14T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Journal%20CME%2041.09%20-%20Disclosures_14102026031626.pdf" rel="noopener noreferrer" target="_blank"><u>HERE</u></a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Understand the advantages and potential applications of TPS compared with other noninvasive brain stimulation approaches</p><p>2. Assess the study design, eligibility criteria, and imaging methods used to evaluate TPS in Parkinson’s disease</p><p>3. Evaluate changes in motor activation and white matter integrity following TPS, including findings from fMRI and DTI</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Journal-CME-41.09-Transcranial-Stimulation-enhances-dexterity-in-Parkinsons-disease-A-randomized-sham-controlled-trial.htm Journal CME 41.09: Transcranial Stimulation enhances dexterity in Parkinson's disease: A randomized sham-controlled trial Journal CME 41.09 2026-10-14T18:00:57.963 0 0 Experienced / Intermediate Journal CME CME English On-Demand Clinician Fellow Industry Researcher Resident USA
Approach and Management of Restless Legs Syndrome
On Demand
Interactive
60 Minutes
Foundational / Beginner
CME Credits:1.001133 <p>This course offers an in-depth exploration of Restless Legs Syndrome (RLS), covering the pathophysiology of RLS, latest diagnostic criteria, key differential diagnoses, and evidence-based treatment approaches, including pharmacological and non-pharmacological options.<br /></p> Other Movement Disorders, Restless Legs Syndrome (RLS)/Periodic Limb Movement Disorder (PLMD) Luigi Ferini-Strambi, MD, Maria Paola Mogavero, MD, PhD 60 1.00 https://education.movementdisorders.org/Detail/1133/Approach-and-Management-of-Restless-Legs-Syndrome https://education.movementdisorders.org/Upload/ActivityImages/05INTERACT-51-001-rls-202x1087655.jpg 2026-09-18T00:00:00 2029-09-18T00:00:00 <p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Final Disclosure Block_Approach and Management of Restless Legs Syndrome_16092026115929.pdf" rel="noopener noreferrer" target="_blank">HERE</a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>METHOD OF PARTICIPATION </strong></p><p>Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed in the Accreditation Statement, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><span style="background-color: null;"><strong>FACULTY</strong></span></p><p><span style="background-color: null;">Luigi Ferini-Strambi, MD - Vita Salute Raffaele Turro - Milan, Italy</span></p><p>Maria Paola Mogavero, MD, PhD - Oasi Research Institute IRCCS, Troina, Italy, Adjunct Professor of Neurology, University of Milan, Italy</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon the completion of this activity, learners will be able to:</p><p>1. Explain the epidemiology, causes, and pathophysiology of RLS.</p><p>2. Apply disgnostic criteria to accurately identify RLS and distinguish it from similar conditions.</p><p>3. Analyze the pharmacologic and non-pharmacologic treatment options to develop individualized RLS management plans.</p><p>4. Evaluate treatment responses and complications, including augmentation and adverse effects, to optimize ongoing care.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for students, residents, primary care providers, internists, allied health, non-neurology specialists, and industry who have limited to no movement disorder experience.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Approach-and-Management-of-Restless-Legs-Syndrome.htm Approach and Management of Restless Legs Syndrome 2026-09-18T12:00:53.307 0 0 Foundational / Beginner Interactive CME English On-Demand Clinician Fellow Health Professional Industry Resident Student USA
Affiliate Society Video Case Series
Live OnlineAsia / Oceania
Oct 31, 2026 - Feb 27, 2027
Foundational / Beginner
1151 <p>The MDS-AOS Affiliate Society Video Case Series is a live, interactive educational program designed to enhance diagnostic reasoning in movement disorders through expert-guided discussion of authentic clinical video cases. Each session features case presentations from two MDS-AOS affiliate societies followed by panel discussions led by international experts. The three-session series will focus on contemporary themes in movement disorders, including genetic disorders, movement disorders beyond the basal ganglia, and movement disorders that require prompt recognition because of their therapeutic or prognostic implications.</p><p> </p><p><strong>SESSION 1 REGISTRATION DEADLINE:</strong> October 29, 2026<strong><span style="background-color:#ffffff;color:#000000;"></span></strong><span style="background-color:#ffffff;color:#000000;"></span></p> Ataxias, Biomarkers, Biomarkers & Diagnostic Tools, Drug-induced Movement Disorders/Tardive dyskinesia, Functional Movement Disorders, Gait & Balance Disorders, Genetic & Hereditary Disorders, Genetics, Movement Disorders Emergencies, Neuroimaging, Neuropathology, Other Movement Disorders, Rare/Uncommon Movement Disorders, Rating Scales, Restless Legs Syndrome (RLS)/Periodic Limb Movement Disorder (PLMD), Stiff Person syndrome (SPS) 360 0.00 https://education.movementdisorders.org/Detail/1151/MDS-AOS-Affiliate-Society-Video-Case-Series https://education.movementdisorders.org/Upload/ActivityImages/25AOSSERIE-VideoCases_202x108721193.jpg https://education.movementdisorders.org/Upload/BannerImages/26AOSSERIE_783x40470253.jpg 2026-10-31T00:00:00 2027-02-27T00:00:00 <p><br></p><p><br></p> MDS Education <p><img width="87" height="87" src="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/1756240577504_26082025033615.png" class="fr-fic fr-dii"><!--[endif]--><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/26AOSSERIE%20Course%20Schedule_22102026011153.pdf"><strong>Course Schedule</strong></a><strong> </strong><strong> </strong><!--[if !vml]--><!--[if !vml]--><img width="98" height="98" src="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/1756240577600_26082025033616.png" class="fr-fic fr-dii"><!--[endif]--><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/26AOSSERIE%20Faculty%20Listing_22102026115320.pdf"><strong>Course Faculty</strong><strong> </strong></a></p><p><br></p><p><em>Schedule as of October 22, 2026 </em></p><p><br></p><p><strong>REGISTRATION FEES</strong><br><strong>Members:</strong> $0 USD<br><strong>Non-Members:</strong> $0 USD</p><p><br></p><p><strong>COURSE DETAILS</strong><em><br></em><strong>Session 1: Genetics in Movement Disorders </strong></p><p><em>Saturday, October 31, 2026: 04:00 - 06:00 UTC</em></p><p>Cases Presented By: </p><ol><li>Saudi Neurology Society - Movement Disorders Chapter</li><li>Neurological Association of Uzbekistan</li></ol><p><strong>Session 2: Beyond the Basal Ganglia </strong></p><p><em>Saturday, December 5, 2026: 04:00 - 06:00 UTC</em></p><p><br></p><p><strong>Session 3: Movement Disorders You Can’t Afford to Miss </strong></p><p><em>Saturday, February 27, 2027: 04:00 - 06:00 UTC</em></p><p><br></p><p><br></p><p><em>To convert to your local time, please click here: </em><span style="color: rgb(44, 130, 201);"><a href="https://www.timeanddate.com/worldclock/converter.html"><em>https://www.timeanddate.com/worldclock/converter.html</em></a></span></p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p><span style="color: rgb(0, 0, 0);">Upon completion of this activity, learners will be able to:</span></p><ol><li><span style="color: rgb(0, 0, 0);">Recognize characteristic phenomenological features of selected movement disorders using clinical video cases</span></li><li><span style="color: rgb(0, 0, 0);">Compare disorders with similar clinical presentations and formulate appropriate differential diagnoses</span></li><li><span style="color: rgb(0, 0, 0);">Identify clinical features suggestive of genetic disorders and movement disorders arising outside the basal ganglia</span></li><li><span style="color: rgb(0, 0, 0);">Recognize movement disorders requiring urgent evaluation or disease-specific treatment</span></li><li><span style="color: rgb(0, 0, 0);">Apply expert diagnostic reasoning to challenging movement disorder cases in clinical practice</span></li></ol><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for movement disorder specialists, general neurologists, primary care clinicians, clinical fellows, movement disorder fellows, neurology residents, and medical students with an interest in current clinical trends and approaches for diagnosis and treatment of movement disorders.</p> 0 /Courses/Affiliate-Society-Video-Case-Series.htm Affiliate Society Video Case Series 2026-09-01T12:00:55.500 0 0 Foundational / Beginner English Asia / Oceania Live Online Clinician Fellow Resident-Neurology Student-Medical
Neurodegeneration with Brain Iron Accumulation
On Demand
Interactive
60 Minutes
Foundational / Beginner
CME Credits:1.001121 <span style="line-height:115%;">This course aims to provide you with a structured understanding of the approach and management of neurodegeneration with brain iron accumulation. Upon completion of this course, you will be able to discuss different types of neurodegeneration with brain iron accumulations, including age of onset, clinical manifestations, and genetics; differential diagnosis of neurodegeneration with brain iron accumulations and approach to diagnosis including imaging; as well as review treatment approaches in neurodegeneration with brain iron accumulations.</span> Biomarkers, Biomarkers & Diagnostic Tools, Cognitive impairment/Dementia, Genetic & Hereditary Disorders, Genetics, Medications for motor symptoms, Neuroimaging, Neuropathology, Non-motor Symptoms/Disorders, Other Movement Disorders, Physical Therapy/Physiotherapy, Rating Scales, Sensory disorders, Speech Disorders, Therapies-Other, Therapies-Pharmacological Susanne Schneider, MD, Soaham Desai, MD, DM 60 1.00 https://education.movementdisorders.org/Detail/1121/Neurodegeneration-with-Brain-Iron-Accumulation https://education.movementdisorders.org/Upload/ActivityImages/05INTERACT-47-001-Neurodegeneration-with-Brain-Iron-Accumulation--202x108626849.jpg https://education.movementdisorders.org/Upload/BannerImages/05INTERACT-47-001-Neurodegeneration-with-Brain-Iron-Accumulation-734x404812281.jpg 2026-08-21T00:00:00 2029-08-21T00:00:00 <p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available<a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Final%20Disclosure%20Block_Neurodegeneration%20with%20Brain%20Iron%20Accumulation_14072026110011.pdf" rel="noopener noreferrer" target="_blank"> HERE</a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>METHOD OF PARTICIPATION </strong></p><p>Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed in the Accreditation Statement, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><span style="background-color: null;"><strong>FACULTY</strong></span></p><p><span style="background-color: null;">Susanne A. Schneider, MD - University Medical Center of the Johannes, Gutenberg University - Mainz, Germany</span></p><p><span style="background-color: null;">Soaham Desai, MD, DM - Shree Krishna Hospital, Pramukhswami Medical College, Bhaikaka University, Karamsad - Anand, Gujarat, India</span></p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to: </p><p>1. Discuss different types of NBIA, including age of onset. clinical manifestations, and genetics</p><p>2. Discuss the differential diagnosis of NBIAs and approach to diagnosis, including imaging.</p><p>3. Review treatment approaches in NBIAs.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for students, residents, primary care providers, internists, allied health, non-neurology specialists, and industry who have limited to no movement disorder experience.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Neurodegeneration-with-Brain-Iron-Accumulation.htm Neurodegeneration with Brain Iron Accumulation 2026-08-21T00:01:01.720 0 0 Foundational / Beginner Interactive CME On-Demand Clinician Fellow Health Professional Resident USA
Journal CME 41.08: Metabolic and Volumetric Alterations in the Basal Ganglia and the Cerebellum in Dopa-Responsive Dystonia in Symptomatic and Asymptomatic GCH1 Mutation Carriers
On Demand
Journal CME
60 Minutes
Experienced / Intermediate
CME Credits:1.001147 <p>The Journal CME 41.08 article aims to characterize the volumetric and neurometabolic brain changes in GCH1 mutation carriers (MC) and explore their relationship with clinical severity.</p> Basal Ganglia, Biomarkers, Biomarkers & Diagnostic Tools, Dystonia, Etiology & Pathophysiology, Genetics, Hyperkinetic Movement Disorders, Neuroimaging, Neuropathology, Rating Scales Jannik Prasuhn, MD 60 1.00 https://education.movementdisorders.org/Detail/1147/Journal-CME-41-08:-Metabolic-and-Volumetric-Alterations-in-the-Basal-Ganglia-and-the-Cerebellum-in-Dopa-Responsive-Dystonia-in-Symptomatic-and-Asymptomatic-GCH1-Mutation-Carriers https://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg 2026-08-14T00:00:00 2027-08-14T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Journal%20CME%2041.08%20-%20Disclosures_12082026085638.pdf" rel="noopener noreferrer" target="_blank"><u>HERE</u></a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Understand the role of GCH1 and tetrahydrobiopterin in dopamine synthesis</p><p>2. Assess the clinical and imaging methods used to characterize GCH1-related DRD</p><p>3. Evaluate structural and metabolic changes in the basal ganglia and cerebellum associated with GCH1-related DRD</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Journal-CME-41.08-Metabolic-and-Volumetric-Alterations-in-the-Basal-Ganglia-and-the-Cerebellum-in-Dopa-Responsive-Dystonia-in-Symptomatic-and-Asymptomatic-GCH1-Mutation-Carriers.htm Journal CME 41.08: Metabolic and Volumetric Alterations in the Basal Ganglia and the Cerebellum in Dopa-Responsive Dystonia in Symptomatic and Asymptomatic GCH1 Mutation Carriers Journal CME 41.08 2026-08-14T18:00:53.077 0 0 Experienced / Intermediate Journal CME CME English On-Demand Clinician Fellow Industry Researcher Resident USA
Trastornos Integrales del Movimiento: De la Ciencia Traslacional a la Práctica Clínica - Presentado en Español
In-PersonPan America
Santiago, Chile
Dec 09, 2026 - Dec 12, 2026
Foundational / Beginner, Experienced / Intermediate
1142 <p><em> </em></p>"<em>MDS-PAS: Curso integral sobre trastornos del movimiento: de la ciencia traslacional a la práctica clínica – Presentado en español</em>" es un programa educativo de cuatro días que combina dos cursos complementarios en una experiencia de aprendizaje única e integrada. El programa comienza sentando las bases de la ciencia traslacional y explorando los avances científicos y los principios de investigación que impulsan la innovación en el campo de los trastornos del movimiento. Posteriormente, se centra en una revisión clínica exhaustiva de los principales trastornos del movimiento, haciendo hincapié en el razonamiento diagnóstico, el manejo basado en la evidencia, el análisis interactivo de casos y los talleres prácticos. Al integrar estas perspectivas complementarias, el curso tiende un puente entre el descubrimiento científico y la práctica clínica, al tiempo que fortalece la experiencia regional, fomenta la colaboración multidisciplinaria y promueve el establecimiento de redes profesionales en toda América Latina y en la comunidad global de la MDS.<br /><br /><strong>FECHA LÍMITE DE INSCRIPCIÓN: </strong>8 de diciembre de 2026<p><strong> </strong></p> Animal models, Autoimmune, Basal Ganglia, Basic/Translational Neuroscience, Biomarkers, Biomarkers & Diagnostic Tools, Chorea/Huntingtons Disease (HD), Corticobasal Syndrome (CBS)/Corticobasal Degeneration (CBD), Dystonia, Freezing of Gait (FOG), Gene Therapies, Genetics, Hyperkinetic Movement Disorders, Lewy-body dementia (LBD), Microbiome, Multiple Systems Atrophy (MSA), Myoclonus, Neuroimaging, Neuropathology, Parkinson Disease/Hypokinetic Movement Disorders, Parkinson's Disease (PD), Progressive Supranuclear Palsy (PSP), Rating Scales, Synucleinopathy, Tauopathy, Tics/Tourettes syndrome (TS), Tremor/Essential Tremor (ET) 1650 0.00 https://education.movementdisorders.org/Detail/1142/MDS-PAS-Trastornos-Integrales-del-Movimiento:-De-la-Ciencia-Traslacional-a-la-Práctica-Clínica---Presentado-en-Español- https://education.movementdisorders.org/Upload/ActivityImages/26PASBASIC_202x10826235.png 2026-12-09T00:00:00 2026-12-12T00:00:00 Santiago MDS Education <p><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/26PASMD%20Course%20Schedule%20-%20Updated%209.22_03102026012808.pdf" rel="noopener noreferrer" target="_blank"><img width="87" height="87" src="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/1786042837676_06082026020038.png" alt="A simple red calendar icon with a grid layout, featuring two hooks at the top." class="fr-fic fr-dii"></a><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/26PASMD%20Course%20Schedule%20-%20Updated%209.22_03102026012808.pdf" rel="noopener noreferrer" target="_blank"><strong>Horario del curso</strong></a></p><p><strong> </strong><a href="https://form.jotform.com/262175930145153" rel="noopener noreferrer" target="_blank"><img width="112" height="112" src="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/1786042837627_06082026020037.png" alt="A red dollar bill with wings, symbolizing money in flight or financial freedom." class="fr-fic fr-dii"></a><a href="https://form.jotform.com/262175930145153" rel="noopener noreferrer" target="_blank"><strong>Subvención de viaje</strong></a></p><p><strong> </strong><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Final%20Faculty%20Listing_03102026012515.pdf"><img width="98" height="98" src="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/1786042837703_06082026020038.png" alt="A simple red icon depicting a person standing behind a podium." class="fr-fic fr-dii"></a><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Final%20Faculty%20Listing_03102026012515.pdf" rel="noopener noreferrer" target="_blank"><strong>Profesorado del curso</strong></a></p><p><br></p><p><em>Calendario al 22 de septiembre de 2026</em></p><p><em>Fecha límite para la subvención de viaje: 30 de octubre de 2026</em></p><p><u><strong><br></strong></u></p><p><strong>CUOTAS DE INSCRIPCIÓN</strong></p><p><strong>Miembros:</strong> $200 USD</p><p><strong>Miembros (Junior / HP / Ciencias Básicas / Sin cuota):</strong> $100 USD</p><p><strong>No miembros*: </strong>$350 USD</p><p>*Los no miembros que deseen solicitar la afiliación a la MDS para beneficiarse de la tarifa de miembro en este curso deberán tramitar su solicitud a más tardar dos semanas antes del cierre de las inscripciones.</p><p><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/VISA%20STATEMENT%20CANCELLATION%20LANGUAGE_07082026093517.pdf" rel="noopener noreferrer" target="_blank">Haga clic aquí para ver la política de cancelación de cursos regionales de MDS y la información sobre asistencia para visas.</a></p><p><br></p><p><strong>LUGAR DEL CURSO</strong></p><p>Clínica Universidad de los Andes</p><p>Av Plaza 2501, Las Condes, Región Metropolitana</p><p>Santiago, Chile</p><p><br></p><p><strong>OBJETIVOS DE APRENDIZAJE</strong></p><p>Al finalizar esta actividad, los participantes serán capaces de:</p><p> </p><p>1. Explicar las bases moleculares y los mecanismos fisiopatológicos subyacentes a los síndromes parkinsonianos, la distonía, la ataxia, la corea y otros trastornos del movimiento.</p><p>2. Interpretar biomarcadores y modelos relevantes para los trastornos del movimiento, incluyendo neuroimagen, biomarcadores en fluidos, escalas clínicas, modelos animales, modelos celulares y herramientas genómicas.</p><p>3. Aplicar principios genómicos prácticos al abordaje clínico de los trastornos del movimiento, incluyendo el análisis de pedigrí, la interpretación de variantes, el asesoramiento genético y la toma de decisiones basada en casos clínicos.</p><p>4. Reconocer y clasificar los trastornos del movimiento hipocinéticos e hipercinéticos mediante la fenomenología clínica y el análisis basado en video.</p><p>5. Desarrollar planes de manejo basados en la evidencia para la enfermedad de Parkinson, el parkinsonismo atípico, la distonía, la corea, la enfermedad de Huntington, la ataxia, los tics, las mioclonías, los trastornos del movimiento inducidos por fármacos, los trastornos autoinmunes, las urgencias, los trastornos funcionales del movimiento y los trastornos del movimiento en pediatría.</p><p>6. Identificar candidatos adecuados para terapias avanzadas, incluyendo toxina botulínica, estimulación cerebral profunda, terapias asistidas por dispositivos, terapias basadas en genes o ARN y atención multidisciplinaria.</p><p><br></p><p><strong>PÚBLICO OBJETIVO</strong></p><p>Esta actividad está dirigida a médicos clínicos, especialistas en trastornos del movimiento, médicos en formación de subespecialidad (*fellows*), personal de enfermería y otros profesionales de la salud.</p> Santiago 0 /Courses/Trastornos-Integrales-del-Movimiento-De-la-Ciencia-Traslacional-a-la-Prctica-Clnica---Presentado-en-Espaol.htm Trastornos Integrales del Movimiento: De la Ciencia Traslacional a la Práctica Clínica - Presentado en Español 2026-08-11T12:00:56.477 0 0 Foundational / Beginner Experienced / Intermediate Spanish Pan America In-Person Clinician Clinician-Movement Disorder Specialist Fellow Health Professional Health Professional-Nurse Chile